Review article · 2019

Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis

Katsuhiko Hagi

Asian College of Neuropsychopharmacology · Published 1 October 2019

View at the publisherCite this paper

In brief

“Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis” is a 2019 review article by Katsuhiko Hagi, published in Asian College of Neuropsychopharmacology. OpenAlex counts 0 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hagi, K. (2019). Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis. Asian College of Neuropsychopharmacology. https://confit.atlas.jp/guide/event/ascnp2019/subject/CNP-P11-1/detail

MLA 9

Hagi, Katsuhiko. “Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis.” Asian College of Neuropsychopharmacology, 2019. https://confit.atlas.jp/guide/event/ascnp2019/subject/CNP-P11-1/detail.

Chicago

Hagi, Katsuhiko. 2019. “Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis.” Asian College of Neuropsychopharmacology. https://confit.atlas.jp/guide/event/ascnp2019/subject/CNP-P11-1/detail.

Harvard

Hagi, K. (2019) ‘Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis’, Asian College of Neuropsychopharmacology. Available at: https://confit.atlas.jp/guide/event/ascnp2019/subject/CNP-P11-1/detail.

IEEE

K. Hagi, “Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis,” Asian College of Neuropsychopharmacology, 2019.

BibTeX

@article{hagi2019benefits,
  title     = {{Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis}},
  author    = {Hagi, Katsuhiko},
  journal   = {Asian College of Neuropsychopharmacology},
  year      = {2019},
  url       = {https://confit.atlas.jp/guide/event/ascnp2019/subject/CNP-P11-1/detail}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • atypical antipsychotics
  • pediatric schizophrenia
  • children and adolescents
  • treatment benefit
  • treatment harms
  • antipsychotic adverse effects

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Hagi, K. (2019). Benefits and harms of atypical antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis. Asian College of Neuropsychopharmacology. https://confit.atlas.jp/guide/event/ascnp2019/subject/CNP-P11-1/detail

How many times has this paper been cited?

0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Katsuhiko Hagi.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.